This dual involvement of CB2R and PPARγ in mediating BCP effects has also been reported in models of systemic inflammation and metabolic dysfunction, including colitis, dyslipidemia, and collagen-induced arthritis [20,49]. The gene discussed is PPARG; the disease is metabolic syndrome.